Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group, Ambulatory Safety and Efficacy Study of ARK-E021 Topical Foam of 5% and 10% in Subjects With Mild to Moderate Acne Vulgaris.

NCT01494285 is registered in ClinicalTrials.gov with M. Arkin 1999 Ltd. as lead sponsor.

NCT NCT01494285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01494285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-blind, Placebo-controlled, 3-arm, Parallel-group, Ambulatory Safety and Efficacy Study of ARK-E021 Topical Foam of 5% and 10% in Subjects With Mild to Moderate Acne Vulgaris.
Lead sponsor
M. Arkin 1999 Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2012
Completion date
October 31, 2013
Enrollment
157 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris